Improving Regulatory Transparency for New Medical Therapies Act.
Saved in:
| Other title: | Act to Amend the Controlled Substances Act with Respect to Drug Scheduling Recommendations by the Secretary of Health and Human Services, and with Respect to Registration of Manufacturers and Distributors Seeking to Conduct Clinical Testing. |
|---|---|
| Format: | Government Document Book |
| Language: | English |
| Published: |
[Washington, D.C.] :
[U.S. Government Publishing Office],
[2015]
|
| Subjects: |